Cryotomy in a Mohs service: the Welsh experience

Pioneered in the 1930s in the USA by Dr Frederic Mohs (1910–2002), Mohs micrographic surgery is a highly effective means of treating certain types of primary skin cancer, most commonly basal cell carcinoma (BCC) and squamous cell carcinoma (SCC). These occur most frequently on the head and neck, with clinically invisible microscopic extensions, or situated on critical anatomical structures such as the nose, eyelid, lip or ear. It is vital to remove all the tumour to prevent recurrence, yet also desirable to minimise loss of normal skin tissue to avoid cosmetically unsightly wounds. The Thermo Scientific Cryostar cryostat can help to optimise workflow and throughput in the modern Mohs clinic, enabling more patients to be seen per clinic session.

This story is Premium Content and is only available to registered users. If you don't already have an account, please register with us completely free of charge.

Other news

Upcoming Events

Challenges in the clinical biochemistry laboratory and beyond

The Royal College of Pathologists
28 February 2019

British Society for Haematology 59th Annual Scientific Meeting

SEC Glasgow
1-3 April 2019

Focus 2019

SEC Glasgow
1-3 May 2019

Respiratory Microbiology - A Day of Inspiration

Royal Air Force Museum, Hendon
16 May 2019

Clinical and Laboratory Haemostasis 2019

The Atrium Conference Centre, Sheffield Hallam University
5-6 June 2019

Latest Issue

Pathology In Practice

Pathology In Practice

Dec 2018

Molecular diagnostics and LAMP technology

Register now to apply for regular copies of Pathology In Practice and free access to premium content, as well as our regular newsletters.